Navigation Links
Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
Date:1/24/2013

Actavis acquisition; the difficulty of predicting the timing and outcome of pending or future litigation and government investigations and risks that an adverse outcome in such litigation or investigations could render Actavis liable for substantial damages or penalties; risks that resolution of patent infringement litigation through settlement could result in investigations or actions by private parties or government authorities or agencies; the impact of competitive products and pricing; risks related to fluctuations in foreign currency exchange rates; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and regulatory agency approvals or actions, if any; risks and uncertainties normally incident to the pharmaceutical industry, including product liability claims and the availability of product liability insurance on reasonable terms; market acceptance of and continued demand for Actavis' products; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with governmental regulations applicable to Actavis' facilities, products and/or businesses; changes in the laws and regulations, including Medicare, Medicaid, and similar laws in foreign countries affecting, among other things, pricing and reimbursement of pharmaceutical products and the settlement of patent litigation; and such other risks and uncertainties detailed in Actavis' periodic public filings with the Securities and Exchange Commission, including but not limited to Actavis' Annual Report on Form 10-K for the year ended December 31, 2011 and Actavis' Quarterly Repo
'/>"/>
SOURCE Watson Pharmaceuticals, Inc.; Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Watson Acquires Uteron Pharma SA
2. Watson to Present at the 2012 Piper Jaffray Health Care Conference
3. Watson to Present at the 2012 Annual Credit Suisse Healthcare Conference
4. Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
5. Watson Announces Global Generics Management Team
6. Watson Announces New Name -- Actavis -- for Global Operations
7. Cleveland Clinic and IBM Work to Advance Watsons Use in the Medical Training Field
8. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
9. Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference
10. Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
11. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ... System as a non-invasive, wireless continuous glucose monitoring system, ... Chairman and Interim CEO of Echo Therapeutics, will present ... Conference. Mr. Doman will make a ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
(Date:4/23/2014)... Hopkins scientists report that rats exposed to high-energy particles, ... space mission, show lapses in attention and slower reaction ... low dose ranges. , The cognitive impairments which ... the animals appear to be linked to protein ... if found to hold true in humans, suggest it ...
(Date:4/23/2014)... enzyme pathway that helps prevent new cells from receiving ... has been directly linked to cancer and other diseases. ... near the end of cell division, the enzyme Cdc14 ... DNA are fully repaired before the parent cell distributes ... helps safeguard against some of the most devastating genome ...
(Date:4/23/2014)... area of the gastro-intestinal tract has long been considered ... at the Sahlgrenska Academy have used refined microscopic techniques ... inner surface of the gastro-intestinal tract is only as ... Fndriks. , The digestive tract, which passes from the ... has a length of about 5 meters in a ...
(Date:4/23/2014)... predict which patients might suffer potentially fatal side-effects from ... assesses brain scans using pattern recognition software similar to ... been developed by researchers at Imperial College London. Results ... which used the software are published in the journal ... 15 million people each year worldwide. Ischemic strokes are ...
(Date:4/23/2014)... Bethesda, MD (April 23, 2014) The American ... announce the 2014 AGA Research Scholars. The AGA ... young investigators to develop independent and productive research ... Research Scholar Awards fund an additional year allowing ... is committed to supporting junior faculty who are ...
Breaking Medicine News(10 mins):Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:AGA announces 2014 Class of AGA Research Scholars 2
... Supreme Court today issued notices to the Centre and Medical Council ... by doctors. // ,A bench of Justice Arijit Pasayat ... respond to the PIL filed by People for Better Treatment, within ... file its rejoinder to the replies of Centre and MCI., ...
... Lebanon will not have to wait for access to public ... it will waive the mandatory three-month waiting period for OHIP ... the Health Minister George Smitherman the evacuees have undergone a ... the "health care they need when they need it the ...
... deaths in municipal hospitals in Mumbai from Saturday morning ... and another of suspected leptospirosis.// ,The Brihanmumbai ... on Sunday with various diseases — 208 with fever, ... vomiting,; 10 of 'suspected dengue', 19 with jaundice and ...
... BMA Cymru Wales' response to growing concerns amongst Welsh ... ,Launching the guidance document, chairman of ... “Unwanted and unprofessional behaviour in the workplace that is ... suffer from bullying and harassment like any other profession. ...
... the country do not disclose their status at workplaces ... ,"Seventy-four per cent of the employees have ... the remaining 26 per cent who have disclosed their ... the hands of the employer," a UNDP-NACO-NCAER report on ...
... organizations urge anyone over age 65 to get yearly ... preventing flu and its complications among older adults, according ... ,Similarly, there is a little evidence that vaccinating healthcare ... study found. ,The reviews appear in the ...
Cached Medicine News:Health News:Doctors' Bid to End Bullying and Harassment in the Workplace 2Health News:Only Modest Benefit of Flu Shots Among Older Adults 2Health News:Only Modest Benefit of Flu Shots Among Older Adults 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: